Showing results (2211-2220 of 2,288) with videos related to
Sort By:
Pageof 229
Metabolic Engineering|November 21, 2012
Recombinant strains for the enhanced production of bioengineered rapalogsSteven G Kendrew, Hrvoje Petkovic, Sabine Gaisser, et al.Nature Communications|January 9, 2020
Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapyHayley C Affronti, Aryn M Rowsam, Anthony J Pellerite, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 1, 2025
An Agrin-YAP/TAZ Rigidity Sensing Module Drives EGFR-Addicted Lung TumorigenesisReza Bayat Mokhtari, Divyaleka Sampath, Paige Eversole, et al.Journal of Pediatric Orthopedics|August 9, 2019
Incidence of Congenital Spinal Abnormalities Among Pediatric Patients and Their Association With Scoliosis and Systemic AnomaliesPeter G Passias, Gregory W Poorman, Cyrus M Jalai, et al.Genomics|April 8, 2021
Key genetic variants associated with variation of milk oligosaccharides from diverse human populationsJanet E Williams, Michelle K McGuire, Courtney L Meehan, et al.Scientific Reports|September 15, 2023
A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring StudyAnastasiya Slyepchenko, Rudolf Uher, Keith Ho, et al.Translational Psychiatry|October 10, 2019
Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressantsChelsey Ju, Laura M Fiori, Raoul Belzeaux, et al.Journal of Medical Microbiology|November 12, 2024
Chronic Strongyloides stercoralis infection in Fijian migrants to the UKWilliam D Nevin, Jake Melhuish, Jayne Jones, et al.Translational Psychiatry|October 12, 2024
Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression studyBenjamin Schwartzmann, Raaj Chatterjee, Yasaman Vaghei, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2020
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) ReportKatharine Dunlop, Sakina J Rizvi, Sidney H Kennedy, et al.Pageof 229